Reaction Details Report a problem with these data
Target
Glycerophosphocholine phosphodiesterase GPCPD1
Ligand
BDBM86694
Substrate
n/a
Ki
>10000±n/a nM
Comments
PDSP_4918
Citation
 Miyata, N; Seki, T; Tanaka, Y; Omura, T; Taniguchi, K; Doi, M; Bandou, K; Kametani, S; Sato, M; Okuyama, S; Cambj-Sapunar, L; Harder, DR; Roman, RJ Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke. J Pharmacol Exp Ther 314:77-85 (2005) [PubMed]  Article 
Target
Name:
Glycerophosphocholine phosphodiesterase GPCPD1
Synonyms:
GDE5 | GPCP1_HUMAN | GPCPD1 | KIAA1434 | Phosphodiesterase 5 | Putative glycerophosphocholine phosphodiesterase GPCPD1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
76021.40
Organism:
Homo sapiens (Human)
Description:
Phosphodiesterase 5 0 HUMAN::Q9NPB8
Residue:
672
Sequence:
MTPSQVAFEIRGTLLPGEVFAICGSCDALGNWNPQNAVALLPENDTGESMLWKATIVLSRGVSVQYRYFKGYFLEPKTIGGPCQVIVHKWETHLQPRSITPLESEIIIDDGQFGIHNGVETLDSGWLTCQTEIRLRLHYSEKPPVSITKKKLKKSRFRVKLTLEGLEEDDDDRVSPTVLHKMSNSLEISLISDNEFKCRHSQPECGYGLQPDRWTEYSIQTMEPDNLELIFDFFEEDLSEHVVQGDALPGHVGTACLLSSTIAESGKSAGILTLPIMSRNSRKTIGKVRVDYIIIKPLPGYSCDMKSSFSKYWKPRIPLDVGHRGAGNSTTTAQLAKVQENTIASLRNAASHGAAFVEFDVHLSKDFVPVVYHDLTCCLTMKKKFDADPVELFEIPVKELTFDQLQLLKLTHVTALKSKDRKESVVQEENSFSENQPFPSLKMVLESLPEDVGFNIEIKWICQQRDGMWDGNLSTYFDMNLFLDIILKTVLENSGKRRIVFSSFDADICTMVRQKQNKYPILFLTQGKSEIYPELMDLRSRTTPIAMSFAQFENLLGINVHTEDLLRNPSYIQEAKAKGLVIFCWGDDTNDPENRRKLKELGVNGLIYDRIYDWMPEQPNIFQVEQLERLKQELPELKSCLCPTVSRFVPSSLCGESDIHVDANGIDNVENA
  
Inhibitor
Name:
BDBM86694
Synonyms:
N'-(3-Chloro-4-morpholinophenyl)-N-hydroxyformamidine | TS-011
Type:
Small organic molecule
Emp. Form.:
C11H14ClN3O2
Mol. Mass.:
255.701
SMILES:
ONC=Nc1ccc(N2CCOCC2)c(Cl)c1 |w:3.3|
Structure:
Search PDB for entries with ligand similarity: